Top Global News EF Hutton initiates coverage of Viracta Therapeutics at ‘buy’ with a price target of $10.00 By Ronda Wimm July 31, 2023 0 120 Share FacebookTwitterPinterestWhatsApp Must read Michella Filipowitz: A Journey of Dreams, Art, and Triumph Over Challenges Century Communities Announces Quarterly Cash Dividend Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates SMART Global finalizes additional senior notes sale Ronda Wimm Share FacebookTwitterPinterestWhatsApp Previous articleTrophy properties are all the rage right now, Jonathan Spears saysNext articleEF Hutton initiates coverage of Pyxis Oncology at ‘buy’ with a price target of $15.00 More articles Century Communities Announces Quarterly Cash Dividend Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates SMART Global finalizes additional senior notes sale Latest article Michella Filipowitz: A Journey of Dreams, Art, and Triumph Over Challenges Century Communities Announces Quarterly Cash Dividend Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates SMART Global finalizes additional senior notes sale Wall Street firms to pay over $470 million to settle with US regulators over texting
